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Albendazole (ABZ) is a therapeutic benzimidazole used to treat giardiasis that targets
β-tubulin. However, the molecular bases of ABZ resistance in Giardia duodenalis are
not understood because β-tubulin in ABZ-resistant clones lacks mutations explaining
drug resistance. In previous work we compared ABZ-resistant (1.35, 8, and 250 μM)
and ABZ-susceptible clones by proteomic analysis and eight proteins involved in
energy metabolism, cytoskeleton dynamics, and antioxidant response were found as
differentially expressed among the clones. Since ABZ is converted into sulphoxide (ABZ-
SO) and sulphone (ABZ-SOO) metabolites we measured the levels of these metabolites,
the antioxidant enzymes and free thiols in the susceptible and resistant clones.
Production of reactive oxygen species (ROS) and levels of ABZ-SO/ABZ-SOO induced
by ABZ were determined by fluorescein diacetate-based fluorescence and liquid
chromatography respectively. The mRNA and protein levels of antioxidant enzymes
(NADH oxidase, peroxiredoxin 1a, superoxide dismutase and flavodiiron protein) in
these clones were determined by RT-PCR and proteomic analysis. The intracellular
sulfhydryl (R-SH) pool was quantified using dinitrobenzoic acid. The results showed
that ABZ induced ROS accumulation in the ABZ-susceptible Giardia cultures but not
in the resistant ones whilst the accumulation of ABZ-SO and ABZ-SOO was lower in
all ABZ-resistant cultures. Consistent with these findings, all the antioxidant enzymes
detected and analyzed were upregulated in ABZ-resistant clones. Likewise the R-SH
pool increased concomitantly to the degree of ABZ-resistance. These results indicate
an association between accumulation of ABZ metabolites and a pro-oxidant effect of
ABZ in Giardia-susceptible clones. Furthermore the antioxidant response involving ROS-
metabolizing enzymes and intracellular free thiols in ABZ-resistant parasites suggest that
this response may contribute to overcome the pro-oxidant cytotoxicity of ABZ.
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Introduction
Giardia duodenalis (syn. G. lamblia, G. intestinalis) is the pro-
tozoan causing giardiasis that is a leading cause of parasitic
diarrheal disease in humans and animals. According to esti-
mations of the World Health Organization (WHO), giardiasis
accounts for almost a billion cases worldwide with ∼3 billion
people living in areas in which the incidence of the infection is
around 30% (Escobedo et al., 2010). The disease incidence may
increase due to increasing migrations from and to highly endemic
countries (Ekdahl and Andersson, 2005) and eventual climate
changes (Parkison et al., 2014). The socioeconomic and clinical
impact of giardiasis has prompted its inclusion within theWHO’s
Neglected Diseases Initiative (Savioli et al., 2006). The control
of this infection requires both the inactivation of the infectious
cysts disseminated in the environment and the elimination of
pathogenic trophozoites that attach to small intestinal epithe-
lium. Fatty to watery diarrhea is a hallmark of acute and chronic
giardiasis that in children may result into malabsorption, failure
to thrive and deﬁcit in weight gain. Adult asymptomatic carriers
are frequently observed (Adam, 2001; Escobedo and Cimerman,
2007).
To date, vaccines for giardiasis are only available for ani-
mals and the control of Giardia infections in humans relies on
improvements in sanitation and hygiene (Olson et al., 2000).
Currently available antigiardial drugs include 5-nitro derivatives
of imidazole (metronidazole, tinidazole), furan (furazolidone)
and thiazole (nitazoxanide) as well as alternative drugs such
as acridines (quinacrine, chloroquine), aminoglycosides (paro-
momycin) and benzimidazoles [albendazole (ABZ), mebenda-
zole]. Although 5-nitro derivatives of imidazole have a high
overall eﬃciency according to non-randomized clinical trials
(60–100%; Busatti et al., 2009), therapeutic failures occur in 20%
of individuals in spite of the compliance of drug dosage and dura-
tion (Upcroft, 1998). The reasons for failures of drug treatment
vary among patients and these include: reinfections, inadequate
doses in drug treatment, immunosuppression, drug sequestration
in the gallbladder or pancreatic ducts, and infections caused by
drug resistant in Giardia (Nash et al., 2001).
Since 1990, ABZ (methyl [5-(propylthio)-1H-benzimidazole-
2-yl] carbamate, ABZ), was used in combination with mebenda-
zole to treat giardiasis. Although ABZ is as eﬀective as metron-
idazole against giardiasis, the eﬃcacy of ABZ may vary signif-
icantly (25–90%) depending on the duration of the treatment
(1–5 days; Watkins and Eckmann, 2014). Failures of drug treat-
ments for giardiasis have been reported when ABZ is used
alone (Kollaritsch et al., 1993; Brasseur and Favennec, 1995;
Nash et al., 2001) and when ABZ has been used in combi-
nation with metronidazole (Abboud et al., 2001; Mørch et al.,
2008). Benzimidazoles are given at single dose to deworm chil-
dren at 6 month-intervals (i.e., a suboptimal regime for gia-
rdiasis) in community- or cohort-based programs in endemic
regions of Mexico, Bangladesh, and Bolivia This results in poor
elimination of Giardia trophozoites (Quihui-Cota and Morales-
Figueroa, 2012) and an increase in Giardia burdens among the
patients (Northrop-Clewes et al., 2001; Blackwell et al., 2013). In
this context, in vitro studies suggest that ABZ-susceptible and
ABZ–resistant G. duodenalis trophozoites subpopulations may
coexist in culture and continuous exposure to sublethal (e.g.,
IC50) ABZ concentrations could render not only variant pro-
portions of these subpopulations (Argüello-García et al., 2004)
but variations in gene expression (Argüello-García et al., 2009).
When ABZ concentration is continuously increased in cultures
the surviving parasites may be derived from the selection of drug-
resistant trophozoites or by the adaptation of drug-susceptible
ones. Thus ABZ resistance in giardiasis is an issue of grow-
ing concern for public health. In order to identify and analyze
the mechanism(s) involved in ABZ resistance in G. duodenalis,
cultures able to grow in the presence of 1.35, 8 and 250 μM
ABZ [minimal lethal concentration (MLC) of parent WB strain:
0.32 μM] were obtained by continuous exposure of tropho-
zoite subculture under increasing sub-lethal drug concentrations
(Argüello-García et al., 2009). Since speciﬁc mutations at hot-
spot amino acid positions (50, 134, 165, 167, 198, and 200) in
β-tubulin were associated with ABZ-resistant helminthic para-
sites (Venkatesan, 1998), these positions were initially analyzed
in ABZ resistant Giardia clones; however, no mutations were
found at these sites (Argüello-García et al., 2009). Further pro-
teomic and RT-PCR analyses showed a subset of seven genes
that were upregulated in the ABZ-resistant clones at the pro-
tein and mRNA levels. Some of these genes encoded proteins
that are involved in cytoskeletal dynamics (alpha-2-giardin, ran-
binding protein), energy metabolism (phosphoglycerate kinase
and ornithine carbamoyltransferase) and antioxidant response
(NADH oxidase; Paz-Maldonado et al., 2013). These data are
consistent with the notion that ABZ not only aﬀects parasite
microtubules but also glucose uptake (Vinaud et al., 2008) and
the induction of oxidative stress in the parasites (Docampo, 1990;
Cvilink et al., 2009a). This stress is likely to play an important
role in the drug-resistant phenotype since ABZ may be oxidized
by phase I enzymes into sulphoxide (ABZ-SO) and sulphone
(ABZ-SOO) metabolites that in turn could play a role in the par-
asite susceptibility or resistance to this drug (Cvilink et al., 2008,
2009b).
In this work we analyzed the pro-oxidant activity of ABZ
to assess the production of its metabolites, and to determine
the presence and levels of antioxidant components in drug-
susceptible and –resistant G. duodenalis clones in order to
unravel the eﬀector mechanisms involved in ABZ-resistance in
this parasite.
Materials and Methods
Trophozoite Cultures
The ABZ-resistant clones able to grow under 1.35, 8, and
250 μM concentrations of this drug were obtained as previ-
ously described (Argüello-García et al., 2009). A control culture
of an ABZ-susceptible clone grown in the presence of 0.5% v/v
dimethylformamide (DMF: vehicle), were used throughout this
study. Trophozoites were axenically sub-cultured in 4.5ml screw-
capped vials, tubes or bottles at 37◦C in modiﬁed Diamond’s
TYI-S-33 medium (ATCC no. 1404; Keister, 1983). Parasites
were harvested at late-log phase by chilling culture tubes on
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ice for 30 min, washed three times in phosphate-buﬀered saline
(PBS) pH 7.2, counted in a haemocytometer and adjusted to the
required cell density.
Determination of ABZ and ABZ-Metabolite
Levels
To assess the conversion of this drug into sulphoxide and sul-
phone metabolites in ABZ-susceptible and –resistant G. duo-
denalis trophozoites, the intracellular concentration of ABZ
species was determined by high performance liquid chromatog-
raphy (HPLC) in cell lysates obtained at diﬀerent time periods
(0–48 h) after exposure of parasites to ABZ. To standardize
this technique, synthetic derivatives of ABZ (sulphoxide, sul-
phone and amino) and of MBZ were previously analyzed by
thin layer chromatography and melting point after dissolv-
ing in water:methanol. Then these components were separated
(loop: 200 μL) using a mixture of acetonitrile:water at dif-
ferent proportions containing 0.5% v/v acetic acid as mobile
phase through a NucleosilTM C18 column (5 μm particle size,
125 × 4.6 mm) coupled to a binary pump (WatersTM 1525) and
a detector with photodiode array (WatersTM 996). In all assays,
chromatographic running was carried out for 13-min to sep-
arate peaks of each ABZ species and MBZ either in cell-free
samples or when added at diﬀerent concentrations to lysates
of non-treated trophozoites. All species were recovered from
cell lysates by ethyl acetate extraction followed by solubilisa-
tion in methanol/water. The corresponding values of the area
under curve (AUC) were analyzed to generate the concentration-
AUC calibration curves in which the experimental values of
AUCs in lysates from ABZ-treated trophozoites were interpo-
lated. This procedure was used to quantify the intracellular
ABZ species. In this assay trophozoites lysates were prepared
after incubation of 50 × 106 parasites (ABZ-susceptible and –
resistant, previously maintained 5 days in ABZ-free medium)
in 15 mL culture tubes in TYI-S-33 medium containing 10 μM
ABZ at 37◦C for diﬀerent time periods. Cells were harvested
as described above and washed three times with PBS contain-
ing 0.2% w/v trichloroacetic acid and three times with PBS
alone. After counting parasites cell pellets were resuspended
in 180 μL deionized sterile water, frozen at −70◦C for 5 min
and thawed at 37◦C for 5 min and this procedure was car-
ried out ﬁve times. Lysates were extracted by adding ethyl
acetate (700 μL) and incubating the lysates at 37◦C for 45 min.
Supernatants were recovered by centrifugation at 750 × g for
10 min and dried under vacuum (SpeedVacTM centrifuge). For
HPLC analysis, all the test samples were resuspended in 50 μL
ethanol, stirred and mixed with 150 μL of MBZ 10 μM in
water as internal standard. Results were expressed as micro-
molar concentration of each ABZ species per 1 × 106 tropho-
zoites.
Production of Reactive Oxygen Species
(ROS) by Trophozoites Exposed to ABZ
To monitor the induction of oxidative stress in ABZ-exposed
G. duodenalis trophozoites, the Image-iTTM Live Green ROS
detection kit (Molecular ProbesTM, USA) was used with some
modiﬁcations. This assay is based in the non-ﬂuorescent 5-(and-
6)-carboxy-2′ , 7′-dichlorodihydroﬂuorescein diacetate (carboxy-
H2DCFDA) that penetrates into the live cells, as deacetylated
by non-speciﬁc intracellular esterases. This compound upon the
presence of non-speciﬁc ROS generated in the cell (particularly
during oxidative stress) is oxidized and it emits bright green
ﬂuorescence that is detected by UV light microscopy using stan-
dard ﬂuorescein ﬁlters. In these assays, 1 × 106 trophozoites
were exposed to ABZ for 24 h at 37◦C, washed three times
with warm PBS, transferred to 1.5 mL microcentrifuge tubes and
labeled in suspension by the addition of 300 μL PBS containing
25 μM carboxy-H2DCFDA for 45 min at 37◦C in the darkness.
Then cells were washed again with PBS, transferred to 10-mL
capped polystyrene tubes and resuspended in 200 μL of this
buﬀer prior to analysis by ﬂuorescence microscopy (microscope
Zeiss Axioskop 40) and ﬂow cytometry (ﬂow cytometer Beckman
FACScalibur II).
Determinantion of the Expression and Levels
of Antioxidant Elements in ABZ-Susceptible
and –Resistant Trophozoites
Proteomic Analyses
Proteomic assays were carried out as previously reported (Paz-
Maldonado et al., 2013). In brief, protein extraction was done
on 1 × 107 trophozoites that were sonicated in the presence of
protease inhibitors (Complete, RocheTM, USA); proteins were
extracted with acetone-trichloroacetic acid-β-mercaptoethanol
and then were precipitated at −20◦C overnight. Pellets were
washed with ice-cold methanol or acetone, dried and resus-
pended in IEF buﬀer containing urea, thiourea, CHAPS,
dithiothreitol (DTT), carrier ampholytes pH 3–10 (Amersham
BiosciencesTM, USA) and bromophenol blue. Protein concen-
trations were quantiﬁed using the Lowry assay with bovine
serum albumin as a standard. For two-dimensional electrophore-
sis, 250 μg of protein were loaded on each IPG dry gel strip
(13 cm, pH 3–10; Amersham BiosciencesTM). After isoelectro-
focusing, strips were reduced with DTT and alkylated with
iodoacetamide. Following slab gel electrophoresis (12.5% acry-
lamide gels) protein spots were stained with silver nitrate.
Three replicate gels were obtained for each clone analyzed.
In this study speciﬁc protein spots corresponding to antiox-
idant enzymes namely NADH oxidase (NADHox), peroxire-
doxin 1a (PXR1a), ﬂavodiiron protein (FDP) and superox-
ide reductase (SOR) were analyzed. As a ﬁrst approach spots
corresponding to the expected molecular weight and isoelec-
tric point of these proteins were deﬁned in stained gels.
To identify the selected spots, tandem mass spectrometry
(MS/MS) was performed using a 3200 Q TRAPTM hybrid
spectrometer (Applied Biosystems/MDS SciexTM, Canada) as
described before (Paz-Maldonado et al., 2013). Database
searching (NCBI-nr) and protein identiﬁcation were carried
out from the MS/MS spectra using the Mascot Software
(http://www.matrixscience.com, Matrix ScienceTM, UK). For
image analysis, stained gels were scanned with LabScan soft-
ware on Imagescanner and analyzed using the Image Master
v 5.0 system (Amersham BiosciencesTM, USA) according to
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manufacturer’s protocols. The following criteria for diﬀeren-
tial protein expression were used: a % volume n-fold > 1.0
of spot was considered as increase of expression or a % vol-
ume n-fold < 1.0 of spot was considered as decrease of
expression in ABZ-resistant clones as compared to sensitive
ones.
mRNA Levels of Antioxidant Enzymes
In order to analyze the relative levels of mRNA expression
of each of the aforementioned antioxidant enzymes in ABZ-
resistant or -sensitive G. duodenalis clones, a standardized
retrotranscription-PCR protocol (end point RT-PCR) was used.
This technique has already provided data consistent with semi-
quantitative proteomics results but with intrinsic higher sensitiv-
ity (Paz-Maldonado et al., 2013). RNA was extracted and puri-
ﬁed from each culture using the TRIzol reagent (InvitrogenTM)
and resulting material was used for cDNA synthesis with the
SuperScriptTM III First-Strand Synthesis System (InvitrogenTM)
following manufacturer’s instructions. To standardize condi-
tions, both RNA and cDNA were quantiﬁed by spectropho-
tometry (Nanodrop model 2000, Thermo ScientiﬁcTM, USA). In
the PCR reactions, 50 ng cDNA from each clone was ampli-
ﬁed using oligonucleotide primer pairs (0.4 μM each primer)
that were designed for test gene loci (nadhox, pxr1a, fdp
and sor) and reference gene loci (protein disulﬁde isomerase-
1 [pdi1] and ubiquitin [ubiq]). Primer sequences and condi-
tions used for primer annealing and ampliﬁcation are listed
in Table 1. In general, primer extension was performed at
72◦C for 45 s, except for nadhox (1 min), with a ﬁnal exten-
sion step at 72◦C for 7 min. After electrophoresis in 2.0%
agarose gels, the semi-quantiﬁcation of amplicons was per-
formed by densitometry using the Image JTM v 1.48 soft-
ware. The ratio of band intensity (test locus/reference locus)
for each ABZ-resistant culture was divided by the corre-
sponding test/reference ratio of the DMF clone to calculate
the fold decrease/increase level of expression of each tested
gene.
Determination of Free Sulfhydryl (R-SH) Pools
The concentration of free thiols in cell lysates from ABZ-
resistant and –susceptible clones was determined using an
adapted 5,5′-dithio-bis(2-nitrobenzoic acid) (DTNB, Elman’s
reagent) method. In this, DTNB reacts with free R-SH groups
and releases 2-nitro-5-benzoate which displays a yellowish color
with absorbance at λ− = 412 nm (Riddles et al., 1979). Assays
were performed in 1 mL-reactions by suspending 1.2 × 107
PBS-washed trophozoites in 900 μL of 45 mM NaH2PO4
at pH 7 and adding 100 μL of 1.5 mM DTNB (SigmaTM,
USA). The mixture was sonicated with six pulses at 12
microns (60% amplitude) with 30 s-intervals until suspension
was clear. After incubation at 37◦C for 10 min, absorbances
were recorded at 412 nm in a SmartSpec 3000 spectropho-
tometer (BioRadTM, USA). To obtain a calibration curve,
lysates were substituted for cysteine (stock = 15.5 mM) and
experimental absorbances were interpolated to express results
as the micromolar concentration of thiols per 1.2 × 107
trophozoites.
Protein Modeling
The tertiary structure of the antioxidant enzymes assessed in the
previous experiments was obtained from amino acid sequences
reported in GiardiaDB using the I-Tasser online server (Zhang,
2008; Roy et al., 2010). Sequences in FASTA format were input
in I-Tasser which performs structural alignments between query
sequences and known templates in the protein databank (PDB)
library. This platform retrieves speciﬁc parameters for con-
structed models as the TM score (range: 0–1), an index reﬂect-
ing the accuracy of alignment for two given structures and
considering the root-mean-square-deviation (RMSD) score that
indicates a measure of the diﬀerences between values predicted
by retrieved models and the values observed in PDB tem-
plates. As recommended, signiﬁcant structure alignments when
TM > 0.5 were considered. The Cscore (range: −5 to 2) is an
index that includes the TM and the RMSD scores and allows
to rank the degrees of similarity between two given protein
structures.
Statistical Analyses
In all experiments the data obtained in assays using ABZ-resistant
and -susceptible clones were quantitatively compared with the
least-square method to linearize calibration curves (Microsoft
Excel 2010TM) and diﬀerences inmean+ SD values were assessed
by the t-student test at a signiﬁcance of P < 0.05.
TABLE 1 | Loci used as test and housekeeping genes in reverse transcriptase-PCR assays.
Locus Orf in GiardiaDB
(GL50803)
Forward and reverse primer sequences
(5′–3′ )
Tm
(◦C)
Product
size (bp)
Cycle
number
Peroxiredoxin 1a (pxr1a)a 16076 AGAAGACCATGGATGCCCGTCCCCATCTCTTCTCC
ATGGTCTTCTTGAACGTCT’
55 628 25
NADH Oxidase LTC (nadhox)a 33769 GTGACGGAGAGGTATGACAAGGTAGTGGGGCTGGAA
GAAAAA
55 1020 20
Flavodiiron protein LTC (fdp)a 10358 AGGAATGGCTCTCTCGTATGACGGTGCTTGCGACTTCA 55 582 25
Superoxide reductase (sor)a GLCHR01 CTTTGGCATCACTAAGGAGCTAGAGCTCCATGTAGTTCTC 52 175 25
Ubiquitin (ubiq)b 7110 GAGCTCATGCAGATCTTCGTCAACCTTCTGGATGGAGTAGT 58 190 25
Protein disulfide isomerase-1 (pdi1)b 29487 ACTCCTCTGCTCCTTGTGCTCCTTCGCTGCTTTCAC 55 456 25
aTest gene; bHousekeeping gene; Primer annealing temperature (Tm); Lateral transfer candidate (LTC).
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FIGURE 1 | Differential levels of accumulation of ABZ and ABZ
metabolites in Giardia duodenalis clones susceptible and resistant to
ABZ. Trophozoites from ABZ-susceptible clone (WBDMF, open triangles) and a
representative ABZ-resistant clone (WBR250, filled squares) were exposed to
10 μM ABZ for the times indicated in X-axis at 37◦C and cell lysates were
analyzed by HPLC using MBZ as internal standard. Chromatography assay was
standardized using cell-free mixtures, adjusted to 13-min lasting elutions and
each ABZ species was separated at the retention time indicated in the
corresponding peak (A). These conditions were used in samples of cell lysates
and the AUCs were used to determine the levels of ABZ (B), ABZ-SO (C), and
ABZ-SOO (D). Results are the mean + SD. of three independent experiments
and asterisks indicate statistical difference at P < 0.05.
Results
ABZ Metabolites are Differentially
Accumulated in G. duodenalis Clones
Susceptible and Resistant to ABZ
In this study, we initially determined if ABZ is metabolized,
i.e., oxidized by G. duodenalis trophozoites. The ABZ-SO and
ABZ-SOO metabolites were identiﬁed using a HPLC protocol
standardized to detect the three ABZ species and MBZ as the
TABLE 2 | Experimental time periods of retention and wavelengths of
emission of ABZ species and MBZ (internal standard) as determined by
HPLC.
Species Retention time (min) λ of emission (nm)
ABZSO 3.668 ± 0.3 221.1 ± 3.5 288.6 ± 3.2
ABZSOO 5.201 ± 0.3 221.2 ± 2.9 284.5 ± 3.5
MBZ 7.593 ± 0.1 221.1 ± 1.8 305.2 ± 0.4
ABZ 9.459 ± 0.5 222.3 ± 2.4 293.3 ± 1.0
internal standard. A discontinuous gradient, starting with 70%
water:30% acetonitrile followed by changes in relative propor-
tions of vehicles to 50:50% (at 5 min), 20:80% (at 8 min), 40:60%
(at 10 min) and returning to 70:30% (at 11 min), produced an
eﬃcient separation of each ABZ species and MBZ (Figure 1A).
Under these conditions ABZ species presented maximal emis-
sion peaks nearby to 221 and 292 nm (Table 2); of these, samples
including cell lysates gave low backgrounds at 292 nm hence
quantitative chromatograms were obtained at that λ. In addition,
the increasing baseline starting at 6-10 min of elution, peaks at
10 min and drops to initial A292 values by 12 min (Figure 1A)
was due to the changing proportions of acetonitrile in the mobile
phase and not by artifacts from any of tested compounds, espe-
cially ABZ and MBZ for which AUCs were obtained considering
these changes in baselines. Likewise controls of ABZ and MBZ-
free cell lysates showed this changing baseline with the absence
of absorbance peaks and the calibration curves rendered reli-
able quantiﬁcations of each drug species (R2 ≥ 0.97). Thus,
the results showed that ABZ ([ ]0 = 10 μM) accumulated at
varying concentrations by either drug-susceptible (WBDMF) or
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–resistant (WBRA250) parasites during the ﬁrst 12 h of expo-
sure and this concentration dropped by 24–48 h (Figure 1B).
Although these concentrations were consistently higher in the
ABZ-susceptible clone from 2 to 48 h, these diﬀerences were not
statistically signiﬁcant, which is likely due to the very short time
in which ABZ remains unbound or unmodiﬁed. This could also
explain the lower levels of ABZ detected in cell lysates as com-
pared to ABZ-SO and ABZ-SOO (see scales in Y-axis). On the
other hand, the oxidized species ABZ-SO and ABZ-SOO were
progressively accumulated by the two clones. However, in the
ABZ-resistant clone WBRA250, these species peaked at 12 h and
were maintained at similar levels at 24 and 48 h when cells were
still viable. At latter times in the WB-DMF clones, an increas-
ing accumulation of ABZ-SO and ABZ-SOO (Figures 1C,D) was
detected and this was concomitant with generalized cell death.
ABZ Elicits Higher ROS Levels in
ABZ-Susceptible Trophozoites
Since ABZ was metabolized into oxidized species, it was of
interest to assess if this pro-drug could induce a state of oxida-
tive stress in G. duodenalis trophozoites. The use of carboxy-
H2DCF as a ﬂuorescent ROS tracer allowed the detection of
these reactive species by ﬂuorescence microscopy. We observed
the distribution of these species in the cytoplasm in the ABZ-
susceptible clone (WBDMF), with most cells displaying a punc-
tuate pattern (Figure 2A). In the cells with altered morphology
(a typical eﬀect of ABZ), bright and diﬀuse ﬂuorescence was
observed (Figure 2A, arrows). This latter pattern was also seen in
some WBDMF trophozoites exposed to tert-butyl hydroperox-
ide (TBHP), which is another ROS-forming compound (arrows
in Figure 2A) that was included as positive control because
unlike ABZ, TBHP does not alter trophozoite morphology.
Interestingly, not all the ABZ-resistant clones displayed sig-
niﬁcant ROS-associated ﬂuorescence (Figure 2A) despite the
exposure of these clones to ABZ concentrations (1.35, 8, and
250 μM) that were higher than the one used with the WBDMF
clone (0.18 μM). These observations were corroborated by
ﬂow cytometry analyses in which the proportions of ﬂuores-
cent cells were quantiﬁed (Figure 2B). In quadrant graphics
and histograms, we observed the displacement of cell ﬂuores-
cence (from R4 to R2 and from left to R1 respectively) in the
WBDMF clone exposed to ABZ or TBHP, and the absence of
such an eﬀect in the representative clone WBR250. In gen-
eral up to 30% of WBDMF cells displayed ROS ﬂuorescence
FIGURE 2 | Determination of ROS produced by ABZ exposure in
ABZ-susceptible and ABZ-resistant clones. Trophozoites from the
ABZ-susceptible clone WBDMF or the representative ABZ-resistant clone
WBR250 were exposed to ABZ (test) or TBHP (positive control) at the
concentrations indicated at the left for 24 h at 37◦C and observed by light
microscopy (LM) and cell fluorescence microscopy (ROS; A). The same samples
were processed for flow cytometry analysis (B) with a window calibrated with
fluorescein filters and readings of 20,000 events per sample. Graphs at the left
are quadrant-based distributions of cells by size/granularity (X-axis) and
fluorescence intensity (Y-axis) and histograms at the right show the quantitative
displacement of cell fluorescence. Arrows indicate cells displaying profuse ROS
staining. Scale bars: 20 μm.
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while in ABZ-resistant clones this proportion was lower
(6–9%).
The Antioxidant Enzymes NADHox and
PXR1a are Overexpressed in ABZ-Resistant
G. duodenalis Trophozoites
Since ABZ was able to induce oxidative stress in ABZ-susceptible
G. duodenalis trophozoites, we examined the expression levels of
some antioxidant enzymes in susceptible and resistant parasites.
After two dimensional gel electrophoresis, the intensity of protein
spots corresponding to antioxidant enzymes as NADHox, PXR1a,
FDP and SORwere evaluated by image analysis, and these regions
of the gel were also excised for tandemMS/MS analysis. FDP and
SOR were elusive to detection because no reproducible spot was
found in gel zones nearby to their expected size and isoelectric
point (Figure 3A). However, NADHox and PXR1a were unequiv-
ocally identiﬁed as peptides covering 41% of NADHox and 5.7%
of Pxr1a amino acid sequences were determined from MS/MS
analysis (score > 50; Table 2). When the sequences of these two
enzymes were submitted to the I-Tasser server, the retrieved pro-
tein models are good quality. For NADHox, the model exhibits
high degree of structural alignment (75%) and a low structural
diﬀerence (6.6 Å) with crystallized analogs contained in PDB. For
Pxr1a these parameters were even more deﬁned (90% and 2.8 Å
respectively; Figures 3B,C respectively). In particular, these giar-
dial molecules display maximal structural identity with bacterial
and archaeal template homologs: gNADHox with Lactobacillus
sanfranciscensis NADHox (PDB entry: 2cduB) and gPxr1a with
Aeropyrum pernix Pxr (PDB entry: 3a2vA).When protein expres-
sion levels were determined, the two enzymes detected displayed
spots with higher intensity in all ABZ-resistant clones and the
WBR250 exhibited the highest increases. Thus NADHox was
overexpressed in the fold range of 2.7–3.1 and for Pxr1a this
range was of 1.4–3.2 (Table 3). These results suggest that at least
two antioxidant enzymes are upregulated at the protein level in
ABZ-resistant clones.
mRNAs of Several Antioxidant Enzymes are
Upregulated in ABZ-resistant G. duodenalis
Trophozoites
Although we did not observe protein spots on the 2-D gels
corresponding to some antioxidant enzymes, this does not nec-
essarily imply that these proteins are absent since they may be
present at cellular levels too low for detection by this method.
Thus RT-PCR was used to examine the mRNA levels of the
genes encoding the antioxidant enzymes and two normalizer
genes (pdi1 and ubiq). As expected all the mRNAs from the
aforementioned loci could be ampliﬁed under the conditions
detailed in Table 1. The mRNAs for three out of four antioxi-
dant enzymes analyzed were upregulated in ABZ-resistant clones
(Figure 4). In the case of pxr1a mRNA, the clones WBR1.35
and WBR250 displayed increases (>2-fold) that were slightly
higher than the one observed in clone WBR8. The increase for
nadhox mRNA was more pronounced in the clone WBR1.35
(≈6-fold) while the remainder ABZ-resistant clones did not show
signiﬁcant changes. The fdp mRNA exhibited an increase as fol-
lows: WBR1.35>WBR8>WBR250. In contrast, the sor mRNA
did not show signiﬁcant changes among the clones. Among the
ABZ-resistant clones displaying mRNA overexpression in the
antioxidant enzymes, the WBR1.35 culture exhibited the highest
increases of these mRNAs.
The Antioxidant R-SH Pool Increases in G.
duodenalis Trophozoites Concomitantly with
the Degree of ABZ Resistance
Since the antioxidant repertoire of a cell usually comprises
enzymes and low MW thiols (R-SH), we were interested in ana-
lyzing the R-SH pool in the ABZ resistance model. The thiol
groups are antioxidant moieties localized in monomeric (e.g.,
cysteine) or oligomeric (e.g., glutathione) amino acids or com-
plex polypeptides that can react with the DTNB reagent. We
were able to determine the total free thiol pool in trophozoite
lysates using calibration curves with reliable accuracy (R2 > 0.95,
Figure 5A). Furthermore, it was possible to detect the inter-
action of DTNB reagent with free intracellular thiols with low
backgrounds levels in these assays due to the use of sonica-
tion to lyze the cells. In Figure 5B are shown the micromolar
concentrations of R-SH groups per 1.2 × 107 trophozoites, a
cell amount useful to obtain detectable absorbance that could
be interpolated in the calibration curves (0.05–0.80). In these
assays there were statistically signiﬁcant increases of R-SH levels
in all ABZ-resistant clones as compared to the ABZ-susceptible
counterpart. Interestingly, there was an increase in the steady-
state R-SH pool levels with increasing ABZ concentrations to
which ABZ-resistant cultures were adapted to grow. All together,
these data were consistent with the notion that ABZ elicits an
antioxidant response in ABZ-resistant trophozoites in which
antioxidant enzymes were over- expressed and the increase on
the R-SH pools might play an important role in the resistant
phenotype.
DISCUSSION
The pathogenic period of giardiasis involves the establish-
ment of trophozoites into the small intestine milieu of sus-
ceptible hosts and the attachment of parasites to the intesti-
nal epithelium. To survive in a hostile microenvironment,
trophozoites needs to cope with potentially cytotoxic factors
such as dietary microbicides, digestive enzymes, bile salts, fatty
acids, mucus as well as the innate or adaptive elements of
the host immune response. In this context, G. duodenalis is
able to display complex responses including antigenic varia-
tion, encystation and secretion of metabolic enzymes and pro-
teases (Ankarklev et al., 2010; Lujan, 2011). However, these
processes are usually bypassed when eﬀective antigiardial com-
pounds are used (Harhay et al., 2010; Beech et al., 2011; Andrews
et al., 2014) since drugs are preferentially directed against
parasitic molecule(s) with crucial function in trophozoite sur-
vival.
Drug resistance in helminthic and protozoal species such as
benzimidazole- or ABZ-resistance has been recognized as a mat-
ter of concern in humans and livestock species. To date, the
β-tubulin locus in ABZ-resistant Giardia generated by in vitro
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FIGURE 3 | Determination of NADHox and Pxr1a overexpression in
ABZ-resistant G. duodenalis clones. Trophozoite lysates from clones
susceptible (WBDMF) and resistant (WBR1.35, WBR8, and WBR250) to ABZ
were separated by two dimensional gel electrophoresis (A) and the zones
matching the expected molecular weight and isoelectric point of NADHox
(dashed circle), FDP (circle), Pxr1a (dashed rectangle) and SOR (rectangle) were
cut and processed by LC-MS/MS. Proteins detected and identified were
NADHox (B) and Pxr1a (C) and the protein model with the scores of quality
parameters is shown in the upper panel. The image analyses of protein spots in
representative gels of each clone displaying differential peak volumes are shown
in the lower panels. Ligands in protein models (ADP for NADHox and peroxide
ion for Pxr1a) are shown in ball conformation.
subculture is the most extensively model studied (Upcroft et al.,
1996; Argüello-García et al., 2009). Since mutations reported in
benzimidazole-resistant helminthes (F167Y, E198A, and F200Y)
are absent in the giardial β-tubulin locus, it is likely that other
mechanism(s) related to drug transport or metabolism are con-
tributing to the resistant phenotype. ABC like eﬄux transporters
(e.g., P-glycoprotein, PgP) are unlikely to be involved in ABZ-
resistant Giardia since this drug, along to MBZ, are not suit-
able substrates for PgP (Dupuy et al., 2010), and we observed
similar kinetics of ABZ accumulation between ABZ-susceptible
and -resistant trophozoites in this study (Figure 1B). Aside
from the direct interaction of ABZ with G. duodenalis β-tubulin
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TABLE 3 | Determination of protein expression levels of antioxidant enzymes in G. duodenalis clones susceptible and resistant to ABZ.
ID of protein spot ORF in GiardiaDB
(GL50803)
Sequence
coverage (%)
MW (kDa) Ip R1.35/DMF R8/DMF R250/DMF Expression
NADH oxidase 33769 41 51.0 6.68 3.01 2.71 3.10 Overexpressed
Peroxiredoxin 1a 16076 5.7 21.0 5.34 1.42 1.45 3.29 Overexpressed
Flavodiiron protein 10358 ND 46.6a 6.90a ND ND ND ND
Superoxide reductase GLCHR01 ND 12.5a 6.28a ND ND ND ND
a Theoretical molecular weight (kDa) and isoelectric point (iP).
FIGURE 4 | Determination of mRNAs of antioxidant enzymes analyzed
by PCR in ABZ-resistant G. duodenalis clones. Total RNA from
trophozoites was reversely transcribed and the resulting cDNA was used to
amplify by PCR four test loci that included pxr1a, nadhox, fdp and sor and
two housekeeping loci (pdi1 and ubiq). Amplicons of expected size were
identified by agarose gel electrophoresis in ABZ-susceptible and –resistant
clones (A). Semi-quantitative densitometry using housekeeping loci to
normalize data showed differential patterns of mRNA overexpression in
ABZ-resistant clones for all antioxidant enzyme loci except sor (B). Data
represent the mean values of three independent assays. M, size standards;
control, PCR in absence of reverse transcriptase using RNA from the
WBDMF clone.
(MacDonald et al., 2004; Aguayo-Ortiz et al., 2013), these obser-
vations suggest an additional cytotoxic role of ABZ as pro-drug
against this parasite.
During ABZ metabolism, new cytotoxic species are generated
that may induce the development of resistance inGiardia tropho-
zoites to this drug. ABZ is a xenobiotic component that in living
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FIGURE 5 | Differential levels of the sulfhydryl pool in G. duodenalis
trophozoites susceptible and resistant to ABZ. (A) Representative
calibration curve using cysteine as standard including the corresponding linear
regression coefficients. (B) Levels of free thiols determined in the
ABZ-susceptible clone (open bar) and the ABZ-resistant clones (dark bars)
using samples of 1.2 × 107 trophozoites from each trophozoite culture. Data
are the mean + SD. of three independent determinations. ∗P < 0.05,
∗∗P < 0.01.
cells is processed by phase I enzymes (most commonly ﬂavin-
containing mono-oxygenases or cytochrome P4540-like,) which
insert two oxygen atoms in the sulfur atom at the 5-propylthio
group of ABZ in a two-step process (Souhaili-El Amri et al., 1988;
Moroni et al., 1995; Cvilink et al., 2009a). Cytochrome P450-like
gene families (e.g., CYP35) have been identiﬁed in helminthes
such as Caenorhabditis elegans (Menzel et al., 2005), but there
are no obvious CYP homologues from searching the GiardiaDB
genome database. The resulting sulphoxide (ABZSO) and sul-
phone (ABZSOO) metabolites still have a parasiticidal eﬀect
albeit ABZSOmay retain more potency than ABZSOO (Souhaili-
El Amri et al., 1988; Bártíková et al., 2010; García-Rodríguez et al.,
2012). These oxidized species, particularly ABZSO, have been
reportedly detected in several helminthes (Cvilink et al., 2008,
2009a,b; García-Rodríguez et al., 2012; Vokrˇál et al., 2013). The
present study is in agreement with a previous study in which
ABZ metabolites were detected in trophozoites by antibody-
based microscopy techniques (Oxberry et al., 2000) and conﬁrms
that G. duodenalis has oxygenases that metabolize both ABZ
and ABZSO. Our results that show the greater accumulation of
ABZSO and ABZSOO in ABZ-susceptible Giardia as compared
to its ABZ resistant counterparts (Figures 1C,D), is in agree-
ment with recent studies in Haemonchus contortus where the
S-oxidation of ABZ determined by LC-MS/MS was also lower in
the resistant BR strain as compared to the susceptible ISE strain
(Vokrˇál et al., 2013). In this context, it is likely that ABZ-resistant
parasites have altered rates of drug metabolization aimed to avoid
ABZSO/ABZSOO levels reaching the cytotoxic levels observed in
ABZ-susceptible ones.
Albendazole could also be cytotoxic by the generation of
oxidative stress in parasites. This phenomenon has been sug-
gested to be induced by other anti-parasitic agents (Docampo,
1990). A hallmark of oxidative stress status is the excessive accu-
mulation of ROS such as oxygen (O2), superoxide anion (.O2−),
peroxide (.O2−2), hydrogen peroxide (H2O2), hydroxyl radi-
cal (.OH), hydroxyl ion (OH−). These species are a result of
endogenous reactions from mitochondrial [superoxide dismu-
tase (SOD)] or membrane-associated (NADPH oxidase and 5-
lipoxygenase) enzymes or from exogenous agents (e.g., pollution,
radiation and xenobiotics including drugs). Cellular damage pro-
voked by ROS includes oxidative transformation of DNA, protein
aminoacids and lipid peroxidation associated to apoptotic or
necrotic cell death. The precise pathway of ROS production by
ABZ in mammals and parasites is yet unknown, hence a direct
participation of ABZSO and ABZSOO cannot be ruled out as
these are S-oxidized species. Moreover benzimidazoles are also
able to induce or modify the oxidative stress status in the host
(Locatelli et al., 2004; Dimitrijevic´ et al., 2012). InG. duodenalis, a
microaerophilic organism, oxidative stress may be induced using
H2O2, drugs (metronidazole) as well as cysteine- and ascorbic
acid-depleted media. The damage observed varies according to
the inducing agent and include cell cycle blockade, apoptotic-like
processes (caspase-independent) and changes in gene expres-
sion proﬁles (Ghosh et al., 2009; Raj et al., 2014). In this study,
ABZ induced ROS accumulation in susceptible trophozoites as
did hydroperoxide, but ABZ had a more marked eﬀect in cell
morphology (Figure 2A). Therefore, the evidence of oxidative
damage to DNA, lipids and proteins, as well as the cell death
process elicited by ABZ have been addressed by our group (publi-
cation in process). Moreover, the production of ABZ metabolites
warrants further studies since three of these metabolites have
been detected at distinct locations within ABZ-exposed tropho-
zoites (Oxberry et al., 2000). In contrast, oxidative stress was not
observed in ABZ-resistant trophozoites (Figures 2A,B), which
indicates that an antioxidant response that avoids accumulation
of both ABZ metabolites and ROS is associated to the resistant
phenotype.
Antioxidant responses are complex but well-orchestrated pro-
cesses that are evolutionarily conserved from bacteria to higher
eukaryotes. These usually involve enzyme systems and molecu-
lar antioxidants based on the tripeptide glutathione, single amino
acids as cysteine or the R-SH pool that are used to scavenge
toxic oxidants and radicals including ROS. G. duodenalis belongs
to one of the earliest lines of eukaryotic descent and lacks the
catalase, SOD, glutathione and glutathione-dependent reductases
and peroxidases. However, Giardia contains alternative antioxi-
dants such as (a) a NADH oxidase (NADHox) and a FDP (A-type
ﬂavoprotein), that can detoxify O2 from trophozoites to form
water (Brown et al., 1996; Di Matteo et al., 2008); (b) a SOR
that converts ·O2− into H2O2 (Testa et al., 2011); (c) 2-cys
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peroxiredoxins (Pxr1a and Pxr1b) with ability to detoxify H2O2
to form oxygen and water (Mastronicola et al., 2014); and (d)
cysteine as the major molecular antioxidant. Based on a reverse
proteomics (eﬀect-to-cause) strategy to search for the expression
of the aforementioned enzymes, two of these enzymes, namely
NADHox and Pxr1a, could be detected and were found overex-
pressed in ABZ-resistant clones. Furthermore, the up-regulation
of NADHox, Pxr1aand FDPmRNAs in ABZ-resistant clones sug-
gest that FDP could be overexpressed at the protein level since
proteomics and RT-PCR assays gave qualitatively similar results
(Figures 3 and 4; Paz-Maldonado et al., 2013). The functional
signiﬁcance of changes of expression of antioxidant enzymes (at
protein and mRNA levels) could reﬂect the levels of substrates
that are processed by these enzymes, or alternatively, by diﬀer-
ences in total catalytical activities between ABZ-susceptible and
–resistant trophozoites. In the ﬁrst scenario, the higher expres-
sion of NADHox, Pxr1a and FDP is likely related to a requirement
to detoxify O2 and H2O2 under constitutive conditions in resis-
tant parasites while ·O2− levels are not increased under ABZ
exposure because SOR mRNA levels were virtually unchanged
(Figure 4). In the second scenario, the likely increased in the
total activity of antioxidant enzymes in ABZ-resistant Giardia
could be a process associated with resistance to ABZ and other
drugs in protozoa and helminthes (Cvilink et al., 2009a; James
et al., 2009; Vokrˇál et al., 2013). Collectively, these observations
support the notion that ABZ-resistance in Giardia is associated
with increased (mRNA or protein) levels of antioxidant enzymes
that could cope more eﬃciently with ROS levels generated during
ABZ-induced oxidative stress.
The role of the increased R-SH pool in antioxidant responses
and drug resistance has been scarcely studied albeit found in
mammalian cell lines, fungal and bacterial models (Cantoni et al.,
1994; Cánovas et al., 2004; Song et al., 2013). The requirement
of Giardia for L-cysteine as a major constituent of its R-SH pool
is largely known. In ABZ-resistant trophozoites, the increasing
thiol pool observed with the increasing degree of ABZ resistance
(Figure 5) suggest that another mechanism to scavenge oxidant
species generated by ABZ metabolization and/or ROS accumu-
lation besides antioxidant enzymes is present. It is also possible
that other drug resistance mechanisms are involved in this phe-
nomenon, such as a higher expression or activity of transporters
for antioxidant molecules as L-cysteine.
Taken together, the results from this work emphasize the pres-
ence of ABZ biotransforming systems in G. duodenalis and the
association of increased levels of antioxidant elements (enzymes
and R-SH pool) with an eﬃcient antioxidant response in ABZ-
resistant trophozoites to avoid accumulation of ABZ metabo-
lites and ROS. This antioxidant response is carried out mostly
by archaeal or bacterial-like molecules present in this parasite.
Nevertheless it is not expected to be ABZ-speciﬁc since peroxire-
doxins have been shown upregulated in trophozoites transfected
with vectors for neomycin or puromycin selection (Su et al., 2007)
and NADHox displayed higher activity in furazolidone-resistant
cultures (Brown et al., 1998). Future studies on the regulation
of the activity of antioxidant enzymes and the R-SH pool will
provide additional insights on the molecular basis underlying
ABZ resistance in this parasite and also for drug development in
giardiasis.
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